Approximately 5% of breast cancer patients carry a deleterious mutation in the Breast Cancer (BRCA1/2) genes, which are required for proper DNA damage repair and correlate with increased risk of developing breast cancer (225, 227, 228). This evidence concerns the gene BRCA1 and breast cancer.